Marc Riedl, M.D.

Dr. Riedl is a Professor of Medicine, Clinical Director of the US HAEA Angioedema Center at the University of California – San Diego (UCSD), and the Training Program Director for Allergy/Immunology at UCSD. Dr. Riedl received his medical degree from the University of Chicago-Pritzker School of Medicine, trained in internal medicine at Washington University/Barnes-Jewish Hospital, St. Louis, and completed fellowships in Allergy/Immunology and Clinical Pharmacology at the University of California – Los Angeles (UCLA). He also received a Master’s degree in Clinical Research at UCLA. Prior to his arrival at UCSD, Dr. Riedl served as Section Chief of Clinical Immunology and Allergy at UCLA.

Dr. Riedl directs the clinical services of the Angioedema Center and leads the Center’s active clinical research program. His professional focus is on angioedema conditions and primary immunodeficiency. He has published extensively in these areas and served on numerous editorial boards and scientific committees, as well as appointed expert panels for the FDA and NIH. Dr. Riedl is an international thought leader in hereditary angioedema and a member of the Medical Advisory Board for the US Hereditary Angioedema Association.